Fennec Pharmaceuticals Inc(FRX-T)TSX
Today's Change
Real-Time Last Update
After Hours Change
After Hours Last Update
Volume
Day Low5.65
Day High6.10
Open:6.10
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Profile
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.